Breaking News Instant updates and real-time market news.

CMCSA

Comcast

$33.82

1.51 (4.67%)

, CMCSK

Comcast

$0.00

(0.00%)

16:22
06/14/18
06/14
16:22
06/14/18
16:22

On The Fly: Top stock stories for Thursday

Stocks started the day in positive territory following early economic data, including the weekly jobless claims data and retail sales figures, that gave the market a lift at the open. The Nasdaq was the strongest index all day, while the Dow was unable to hold its early gains, though it also kept from making much of a decline either. Yesterday, the FOMC raised interest rates by a quarter point and gave somewhat hawkish commentary, while today the ECB kept interest rates unchanged and made dovish comments. The result of the pair of central banks' comments caused the financial stocks to get hit and for the yield curve to flatten further. ECONOMIC EVENTS: In the U.S., retail sales climbed 0.8% in May, and gained 0.9% excluding autos, both of which were better than expected. Initial jobless claims declined 4,000 to 218,000 in the week ended June 9. Import and export prices rose 0.6% in May, both of which were stronger than expected gains. Business inventories rose 0.3% in April with sales up 0.4%, as forecast. In Europe, the ECB announced that it will continue to make net purchases under the asset purchase program at its current monthly pace of EUR30B until the end of September, after which it expects the monthly pace will be reduced to EUR$15B until December, and then ended. The ECB also kept its key interest rates unchanged and said it expects them to remain at their present levels "at least through the summer of 2019 and in any case for as long as necessary" to make sure inflation remains on the expected adjustment path. Meanwhile, CNBC reported that the White House tomorrow plans to roll out tariffs on roughly 800-900 Chinese export products, down from the original list of about 1,300 products published by the U.S. Trade Representative in April. COMPANY NEWS: Comcast (CMCSA) announced last night that it made a "superior proposal" to acquire the businesses that Twenty-First Century Fox (FOXA) has agreed to sell to Disney (DIS) for $35 per share in cash, which it said represents a premium of approximately 19% to the value of Disney's all-stock offer. The $35 per share offer reflects a $65B equity value for 21CF, after giving effect to the proposed spinoff of "New Fox," Comcast stated... Bloomberg reported that Apple (AAPL) is close to a deal to buy distribution rights for the U.S. and some other countries for an animated feature film being produced by Oscar-nominated studio Cartoon Saloon. MAJOR MOVERS: Among the noteworthy gainers was Etsy (ETSY), which surged 26% after it revised its transaction fee structure and updated its fiscal 2018 guidance. Also higher was Insys Therapeutics (INSY), which gained 15% after it said its investigational epinephrine nasal spray showed promise in an early clinical trial. Among the notable losers was Tailored Brands (TLRD), which fell 22% after it reported quarterly results and provided a conservative outlook for fiscal 2018. Also lower was Mylan (MYL), which dropped 5% after the company disclosed that the FDA has identified "minor deficiencies" in its application for approval of generic Advair Diskus. INDEXES: The Dow dipped 25.89, or 0.10%, to 25,175.31, the Nasdaq added 65.34, or 0.85%, to 7,761.04, and the S&P 500 gained 7.33, or 0.26%, to 2,782.96.

CMCSA

Comcast

$33.82

1.51 (4.67%)

CMCSK

Comcast

$0.00

(0.00%)

FOXA

21st Century Fox

$44.57

0.9 (2.06%)

FOX

21st Century Fox

$44.43

1.05 (2.42%)

DIS

Disney

$108.76

2.45 (2.30%)

MYL

Mylan

$39.53

-2.12 (-5.09%)

AAPL

Apple

$190.75

0.04 (0.02%)

ETSY

Etsy

$41.59

8.62 (26.15%)

INSY

Insys Therapeutics

$8.11

1.1 (15.69%)

TLRD

Tailored Brands

$26.17

-7.28 (-21.76%)

  • 18

    Jun

  • 13

    Nov

CMCSA Comcast
$33.82

1.51 (4.67%)

06/14/18
OPCO
06/14/18
NO CHANGE
Target $42
OPCO
Outperform
Disney likely to top bid for Fox entertainment assets, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that Comcast (CMCSA) has bid $65B for a cash offer for Fox's (FOXA) entertainment assets, a 19% premium to Disney's offer (DIS). The analyst believes it does make strategic/financial sense, and Comcast has a great track record on acquisitions. Further, Horan thinks a joint NBC/Fox would be a content powerhouse while expanding the company's presence in Europe with Sky (SKYAY), and slashing OTT video risk. Nonetheless, the analyst believes Disney is likely to top the bid. He reiterates an Outperform rating and $42 price target on Comcast's shares.
06/13/18
06/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Square (SQ) downgraded to Neutral from Buy at Buckingham with analyst Chris Brendler saying he is taking a "breather" following the year-to-date share outperformance but raised his price target to $65 from $55. 2. Yelp (YELP) downgraded to Sell from Hold at Aegis. 3. AT&T (T) was downgraded to Sell from Neutral at MoffettNathanson while Time Warner (TWX) was downgraded to Neutral from Buy at the firm. Time Warner was also downgraded to Market Perform from Outperform at Barrington. 4. Comcast (CMCSA) downgraded to Market Perform from Outperform at Raymond James. 5. Advaxis (ADXS) downgraded to Hold from Buy at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/14/18
LOOP
06/14/18
NO CHANGE
Target $47
LOOP
Buy
21st Century Fox price target raised to $47 from $43 at Loop Capital
Loop Capital analyst Alan Gould raised his price target on 21st Century Fox (FOXA) to $47 following yesterday's confirmation of a Disney (DIS) counterbid from Comcast (CMCSA), saying he expects "at least one additional bid" from each potential acquirer. He also believe that while a Disney merger "offers more regulatory certainty" and its long-term stock value is superior to that of Comcast, the difference in the higher offer from Comcast is too great, requiring more cash or a stock price collar from the former. Gould keeps his Buy rating on 21st Century Fox.
06/14/18
NOMU
06/14/18
NO CHANGE
Target $40
NOMU
Neutral
Nomura sees 'protracted bidding war' for Fox assets
Nomura Instinet analyst Jeffrey Kvaal expects Disney (DIS) to counter Comcast's (CMCSA) offer for 21st Century Fox's (FOXA) assets, which include Premier League sports rights, premium content, and Hulu stake. He sees the stage being set "for a protracted bidding war." The analyst keeps a Neutral rating on Comcast with a $40 price target.
CMCSK Comcast
$0.00

(0.00%)

06/13/18
OPCO
06/13/18
NO CHANGE
OPCO
Perform
Comcast may offer 25% premium to Disney for Fox, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that a U.S. District Court Judge approved AT&T's (T) acquisition of Time Warner (TWX), with no conditions, stating the Department of Justice did not prove the merger would harm competition. The judge also stated he would deny any requests by the DoJ to stay the decision, and as such, the companies are free to close the deal even if the ruling is appealed, he adds. The analyst expects Comcast (CMCSA; CMCSK) will now offer a 25% premium to Disney (DIS) for Fox (FOXA). Horan has a Perform rating on AT&T shares.
06/13/18
KEYB
06/13/18
NO CHANGE
KEYB
Comcast might make competitive offer for Fox soon, says KeyBanc
KeyBanc analyst Brandon Nispel notes that Judge Richard Leon ruled in favor of AT&T (T), without condition, in a suit brought against it by the Department of Justice over its acquisition of Time Warner (TWX). The analyst believes this decision could drive additional media M&A expectations and thinks a formal offer by Comcast (CMCSA; CMCSK) for 21st Century Fox (FOXA) can come as soon as today. Nispel believes 21st Century Fox is the last of the scaled media companies, which makes it appropriate for Comcast to aggressively pursue the company. Additionally, the analyst does not see Verizon (VZ) as a likely buyer of traditional media assets
FOXA 21st Century Fox
$44.57

0.9 (2.06%)

FOX 21st Century Fox
$44.43

1.05 (2.42%)

03/14/18
MACQ
03/14/18
UPGRADE
MACQ
Outperform
Sky upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Guy Peddy upgraded Sky (SKYAY) to Outperform from Neutral after he raised his FY19/20 and FY20/21 EPS by about 16% due to the lower EPL costs. His valuation analysis suggests the current 1075p offer from 21st Century Fox (FOXA) "materially undervalues" Sky and even Comcast's (CMCSA) indicative offer at 1250p "fractionally undervalues" it, Peddy tells investors. What happens next is up to Comcast and Disney (DIS), as Fox is just an intermediary, he added. Peddy raised his price target on Sky shares to 1450p, as he believes tension between those two could lift the offer price at least 10% above his fair value estimate of 1287p.
05/10/18
OPCO
05/10/18
NO CHANGE
Target $42
OPCO
Outperform
Comcast acquisition of Fox would make strategic, financial sense, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that press reports stated Comcast (CMCSA) has lined up $60B in financing to make an all-cash offer for Fox's (FOXA) entertainment assets, representing a 15% premium to Disney's (DIS) offer. While he thinks this has caused half the 30% decline in Comcast's stock year to date, the analyst believes it does make strategic and financial sense, and Comcast has a great track record on acquisitions. Horan thinks a joint NBC/Fox is a content powerhouse while expanding the company's presence in Europe through Sky (SKYAY), and slashing OTT video risk. The analyst reiterates an Outperform rating and $42 price target on Comcast's shares.
05/01/18
MSCO
05/01/18
NO CHANGE
Target $130
MSCO
Overweight
Disney trades at 'historic discount' while building out OTT, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne believes Disney's (DIS) new segment presentation could benefit shares by highlighting Disney's Over-the-top, or OTT, opportunity and providing visibility into the earnings power of its core businesses. If Fox (FOXA) is included and Hulu is consolidated, Swinburne estimates Disney's OTT and Direct-to-consumer businesses grow to roughly $6.5B in gross annual revenues by FY20, while noting that the stock is currently trading at a historical discount to the S&P 500. He maintains an Overweight rating and $130 price target on Disney shares.
03/07/18
WELS
03/07/18
NO CHANGE
WELS
Wells Fargo expects bidding war for Sky
Wells Fargo analyst Marci Ryvicker expects a bidding war for Sky (SKYAY). The analyst believes Sky appears to be more accretive to Disney (DIS)-Fox (FOXA) but more strategic for Comcast (CMCSA; CMCSK). Ultimately, Ryvicker thinks the latter with win but not without a fight from Disney/Fox.
DIS Disney
$108.76

2.45 (2.30%)

MYL Mylan
$39.53

-2.12 (-5.09%)

06/14/18
RBCM
06/14/18
NO CHANGE
Target $42
RBCM
Sector Perform
Mylan's stock may pull back through Q2, says RBC Capital
RBC Capital analyst Randall Stanicky kept his $42 price target and Sector Perform rating on Mylan following yesterday's FDA delay of generic Advair due to "minor deficiencies". The analyst notes that the company may be faced with worse than expressed business pressure and is also concerned that the Street may have over-modeled the Advair contribution, warning that the stock price may pull back through Q2. Stanicky says investors should await a better entry point opportunity on Mylan.
06/14/18
MSCO
06/14/18
NO CHANGE
Target $50
MSCO
Overweight
Morgan Stanley says generic Advair delay a small negative for Mylan
Morgan Stanley analyst David Risinger called Mylan's announcement that generic Advair will not be approved by its June 27 action date a "small negative, but not a major surprise." He sees potential for approval this fall, while noting that the company previously warned with its Q1 earnings release that there was risk that it could need to lower its 2018 guidance range. He keeps an Overweight rating on Mylan shares, citing the stock's low valuation and the company's pipeline opportunities.
06/14/18
WELS
06/14/18
NO CHANGE
WELS
Market Perform
Advair generic delay negative news for Mylan, says Wells Fargo
Wells Fargo analyst David Maris notes that Mylan announced that it received an update from the FDA concerning its generic Advair application and the FDA has identified minor deficiencies that will be relayed in a Complete Response Letter on June 27. While noting that he does not know how long it will take Mylan to respond to the CRL, the analyst says the delay is negative news for the company, but less so from a financial basis than a sentiment basis. Further, Maris believes this delay is important as this is a high-profile product that may already be in market expectations, and the delay may take away some excitement about a near-term catalyst. The fact Mylan said it will determine after getting the CRL whether this has any impact to its 2018 outlook, also creates some uncertainty, he contends. Maris reiterates a Market Perform rating on the shares.
06/14/18
MSCO
06/14/18
NO CHANGE
MSCO
Underweight
Morgan Stanley says Mylan Advair news likely seen as positive for Innoviva
After Mylan (MYL) announced the FDA has identified minor deficiencies that will delay the launch of its generic Advair product, Morgan Stanley analyst Matthew Harrison said he expects the market to view this as a positive for Innoviva (INVA), which he predicts will be up 5% or more on the news. Harrison, who continues to anticipate a generic Advair entry in 2018, keeps an Underweight rating on Innoviva shares.
AAPL Apple
$190.75

0.04 (0.02%)

06/11/18
BFIN
06/11/18
NO CHANGE
BFIN
Rumored Apple iPhone cuts primarily another mix shift, says BlueFin
BlueFin analyst John Donovan contends Apple has "modestly" cut its 2018 model iPhone builds while largely offsetting these cuts with increased builds of the existing models, leading him to lower his 2018 iPhone build estimate by 8M units in aggregate. His research points toward an "extraordinarily sharp ramp" in late August and through September, which not only led him to cut his shipment forecasts for the new iPhone models once again, but adds confidence to his "long-held" position that the LCD model is running 3-4 weeks behind the newer OLED models, Donovan tells investors. The analyst, who now estimates 2018 iPhone builds of 219M and shipments of 221M, said he remains positive on Apple's long-term story, but expects choppiness until September.
06/12/18
KEYB
06/12/18
NO CHANGE
KEYB
Apple iPhone inventories normalize, Galaxy S9 continue to disappoint, says KeyBanc
KeyBanc analyst John Vinh says his latest carrier surveys indicate stable sell-through of Apple's (AAPL) iPhone 8/X, and in line with store expectations. Accordingly, days of inventory have normalized at about 5 DOI and are consistent with healthy levels seen in past cycles, he adds. Conversely, the analyst notes that sell-through of the Samsung's (SSNLF) GS9 continues to deteriorate, accompanied by an increase in DOI. However, he notes a significant reduction in absolute inventories. While GS9 gives him pause, stable sell-through, and normalized iPhone 8/X inventories leave him incrementally more constructive ahead of the 2H ramp of the new iPhone 9 cycle. Vihn recommends investors continue to own Broadcom (AVGO), Skyworks (SWKS), and Synaptics (SYNA).
06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
Morgan Stanley says AT&T ruling may help narrow public/private media value gap
Morgan Stanley analyst Benjamin Swinburne said the court approval of AT&T's (T) acquisition of Time Warner (TWX) without conditions recognized the reality of new competition in the form of content investments from players such as Netflix (NFLX), Google's (GOOGL) YouTube, Amazon (AMZN), Apple (AAPL) and Facebook (FB). This ruling sends a "clear message to other industry players" and market uncertainty on deal prospects could fall, which could mean that equity values will likely rise accordingly, Swinburne tells investors. He notes there remains a large gap, which may now narrow, between private market valuations and public multiples in many parts of media and cable, pointing to Discovery Inc. (DISCK) as an example illustrating that point.
06/13/18
RSBL
06/13/18
NO CHANGE
RSBL
Power Integrations could see upside from Apple design win, says Rosenblatt
Rosenblatt analyst Jun Zhang said "recent noise" surrounding Apple (AAPL) cutting iPhone production seems inaccurate and noted that he forecasts year-over-year production growth in the second half of the year. Zhang also noted that he believes Power Integrations (POWI) could benefit from a potential design win for all iPhone and iPad fast charging solutions. In early trading, Power Integrations is up $2.10, or about 3%, to $79 per share.
ETSY Etsy
$41.59

8.62 (26.15%)

04/10/18
04/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with a Sell at Vertical Group. 2. Philip Morris (PM) initiated with a Buy at Deutsche Bank. 3. Etsy (ETSY) initiated with a Buy at Loop Capital. 4. Zscaler (ZS) initiated with an Outperform at Credit Suisse and Baird, a Strong Buy at Needham, an Equal Weight at Morgan Stanley, Stephens, and Barclays, a Hold at Deutsche Bank, as well as a Neutral at BofA/Merrill and Goldman Sachs. 5. Equifax (EFX) initiated with an Underperform at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/16/18
KEYB
04/16/18
NO CHANGE
Target $33
KEYB
Overweight
KeyBanc sees continued opportunity for Etsy to improve seller services
KeyBanc analyst Edward Yruma thinks Etsy has continued opportunity to improve seller services, and in turn, drive stronger revenue growth. The analyst notes that late last week, Etsy launched the capability for sellers to send targeted offers to customers with abandoned items in the cart, which he believes is a good example of Etsy providing better tools to its seller community and improving its take rate. Yruma has an Overweight rating and $33 price target on the stock.
05/09/18
LOOP
05/09/18
NO CHANGE
Target $37
LOOP
Buy
Etsy price target raised to $37 from $32 at Loop Capital
Loop Capital analyst Laura Champine raised her price target on Etsy to $37, saying that despite the rally of the stock year-to-date, its momentum will likely continue amid the company's ongoing efforts to drive traffic to its platform. Champine expects FY18 revenue to grow 22% after a 25 increase in Q1, as the management "improves search functionality and works with sellers to drive incremental promoted listings and other seller services revenue streams". The analyst keeps her Buy rating on Etsy.
05/01/18
DADA
05/01/18
NO CHANGE
Target $35
DADA
Buy
Etsy price target raised to $35 at DA Davidson ahead of earnings
DA Davidson analyst Tom Forte raised his price target on Etsy to $35 from $33 and kept his Buy rating ahead of the company's earnings next week. Forte notes that despite the 70% rise in the stock price since early February, he continues to see value in shares as investors understand the company's "unique" business model and appreciate the management's execution. The analyst does see some near-term challenges for Etsy as its comparisons for its seller services business become tougher in the second half after the company's mandated payments platform in the second half of last year.
INSY Insys Therapeutics
$8.11

1.1 (15.69%)

07/21/17
JANY
07/21/17
NO CHANGE
Target $16
JANY
Buy
Subsys ANDA somewhat negative for Insys, but not unexpected, says Janney Capital
Janney Capital analyst Ken Trbovich noted that the FDA's Paragraph IV certifications list earlier this week showed that Insys had received an ANDA filing for Subsys on May 22, which he views as "somewhat negative," but also "not unexpected." While the ANDA raises the possibility of a generic sooner rather than later, Trbovich sees no risk for a generic Subsys until 2020 at the earliest and thinks the company's patents could prevent generic entry until as late as 2030. He keeps a Buy rating and $16 fair value estimate on Insys shares.
03/09/18
PIPR
03/09/18
DOWNGRADE
Target $4
PIPR
Underweight
Insys Therapeutics downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst David Amsellem downgraded Insys Therapeutics to Underweight and cut his price target for the shares to $4 from $5. The analyst sees "no basis in reality" for the company's guidance of relatively stable total sales in 2018 versus 2017 given the nature of the opioid crisis. Further, the weak rollout of Syndros "also does not inspire confidence" in the 2018 guidance, Amsellem tells investors in a research note.
TLRD Tailored Brands
$26.17

-7.28 (-21.76%)

05/14/18
JEFF
05/14/18
UPGRADE
JEFF
Buy
Tailored Brands upgraded to Buy from Hold at Jefferies
05/14/18
JEFF
05/14/18
UPGRADE
Target $40
JEFF
Buy
Tailored Brands upgraded to Buy from Hold at Jefferies
As previously reported, Jefferies analyst Randal Konik upgraded Tailored Brands to Buy from Hold with a $40 price target, telling investors in a research note that the company is on a path toward sustainable fundamental improvement and its legacy balance sheet issues are now behind it. Konik sees opportunities in custom clothing as well as a recovery in JoS. A Bank towards prior productivity levels.
06/04/18
JEFF
06/04/18
NO CHANGE
Target $40
JEFF
Buy
Jefferies recommends Tailored Brands after Jos. A. Bank deep dive
Jefferies analyst Randal Konik says a deep dive into Tailored Brands' Jos. A. Bank business, which represents more than 20% of sales, left him increasingly confident in the sustainability of the brand's recovery. Data show Bank's marketing and merchandise initiatives are taking hold, while significant upside remains given productivity levels that are well-below peak and Men's Warehouse, Konik tells investors in a research note. He reiterates a Buy rating on Tailored Brands with a $40 price target.
06/14/18
JEFF
06/14/18
NO CHANGE
Target $40
JEFF
Buy
Tailored Brands earnings pullback a buying opportunity, says Jefferies
Jefferies analyst Randal Konik recommends using the post-earnings pullback today in shares of Tailored Brands as a buying opportunity. With stock having a strong run year-to-date, expectations into the print were somewhat elevated, Konik tells investors in a research note. JoS. A. Bank comps and gross margin were a touch light, but transactions are up, custom is growing, inventory is lean, and the balance sheet is cleaned up, the analyst contends. He sees improving sales trends, share gains, margin expansion and accelerating free cash flow generation benefiting shareholders with a two year view. Konik keeps a Buy rating on Tailored Brands with a $40 price target.

TODAY'S FREE FLY STORIES

01:45
06/21/18
06/21
01:45
06/21/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

RYTM

Rhythm Pharmaceuticals

$26.45

0.21 (0.80%)

22:08
06/20/18
06/20
22:08
06/20/18
22:08
Syndicate
Rhythm Pharmaceuticals 5.732M share Secondary priced at $26.42 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 21

    Jun

AMCX

AMC Networks

$67.45

1.28 (1.93%)

22:06
06/20/18
06/20
22:06
06/20/18
22:06
Downgrade
AMC Networks rating change at Bernstein »

AMC Networks downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

APTX

Aptinyx

$0.00

(0.00%)

20:45
06/20/18
06/20
20:45
06/20/18
20:45
Syndicate
Aptinyx 6.4M share IPO priced at $16.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

AVRO

AvroBio

$0.00

(0.00%)

20:44
06/20/18
06/20
20:44
06/20/18
20:44
Syndicate
AvroBio 5.25M share IPO priced at $19.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

TV

Televisa

$18.25

0.51 (2.87%)

20:43
06/20/18
06/20
20:43
06/20/18
20:43
Downgrade
Televisa rating change at Scotiabank »

Televisa downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

Cemex

$6.33

0.115 (1.85%)

20:42
06/20/18
06/20
20:42
06/20/18
20:42
Upgrade
Cemex rating change at Santander »

Cemex upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PH

Parker-Hannifin

$164.49

0.74 (0.45%)

20:41
06/20/18
06/20
20:41
06/20/18
20:41
Downgrade
Parker-Hannifin rating change at Wells Fargo »

Parker-Hannifin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMT

Kennametal

$37.44

1.11 (3.06%)

20:41
06/20/18
06/20
20:41
06/20/18
20:41
Downgrade
Kennametal rating change at Wells Fargo »

Kennametal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNT

Syntel

$34.07

0.65 (1.94%)

20:40
06/20/18
06/20
20:40
06/20/18
20:40
Downgrade
Syntel rating change at Wells Fargo »

Syntel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MGTA

Magenta Therapeutics

$0.00

(0.00%)

20:28
06/20/18
06/20
20:28
06/20/18
20:28
Syndicate
Magenta Therapeutics 6.667M share IPO priced at $15.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

XERS

Xeris Pharmaceuticals

$0.00

(0.00%)

20:26
06/20/18
06/20
20:26
06/20/18
20:26
Syndicate
Xeris Pharmaceuticals 5.7M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KR

Kroger

$26.21

0.21 (0.81%)

, DRI

Darden

$93.27

-1.34 (-1.42%)

20:25
06/20/18
06/20
20:25
06/20/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

KR

Kroger

$26.21

0.21 (0.81%)

DRI

Darden

$93.27

-1.34 (-1.42%)

CMC

Commercial Metals

$23.67

0.44 (1.89%)

PDCO

Patterson Companies

$22.54

0.07 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 21

    Jun

  • 21

    Jun

  • 28

    Jun

  • 10

    Jul

IIIV

i3 Verticals

$0.00

(0.00%)

20:24
06/20/18
06/20
20:24
06/20/18
20:24
Syndicate
i3 Verticals 6.65M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

KZR

Kezar Life Sciences

$0.00

(0.00%)

20:23
06/20/18
06/20
20:23
06/20/18
20:23
Syndicate
Kezar Life Sciences 5M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

LPL

LG Display

$8.91

-0.015 (-0.17%)

20:08
06/20/18
06/20
20:08
06/20/18
20:08
Periodicals
LG Display discussing early retirement options for workers, Bloomberg reports »

LG Display is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$1.13

-0.02 (-1.75%)

20:05
06/20/18
06/20
20:05
06/20/18
20:05
Hot Stocks
Eldorado Gold provides update on Lamaque exploration and development »

Eldorado Gold is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, RSX

Market Vectors Russia ETF

$20.52

0.22 (1.08%)

19:43
06/20/18
06/20
19:43
06/20/18
19:43
Periodicals
Trump planning to meet with Russia's Putin in Europe next month, Bloomberg says »

Donald Trump and…

SPX

S&P 500

$0.00

(0.00%)

RSX

Market Vectors Russia ETF

$20.52

0.22 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEO

CNOOC

$163.48

2.345 (1.46%)

19:29
06/20/18
06/20
19:29
06/20/18
19:29
Periodicals
CNOOC to proceed with expansion in Canada's oil sands, Reuters reports »

CNOOC's Nexen Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$134.34

-1.815 (-1.33%)

19:14
06/20/18
06/20
19:14
06/20/18
19:14
Periodicals
Toyota to reduce marketing costs to fund new research, Reuters reports »

Toyota Motors has started…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$202.08

4.62 (2.34%)

, GOOG

Alphabet

$1,169.38

1.52 (0.13%)

19:06
06/20/18
06/20
19:06
06/20/18
19:06
Periodicals
FTC chair wants to explore market power of big internet firms, Reuters says »

New U.S. Federal Trade…

FB

Facebook

$202.08

4.62 (2.34%)

GOOG

Alphabet

$1,169.38

1.52 (0.13%)

GOOGL

Alphabet Class A

$1,183.83

5.54 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

RYAAY

Ryanair

$117.11

3.54 (3.12%)

19:01
06/20/18
06/20
19:01
06/20/18
19:01
Periodicals
IAG, Ryanair preparing EU legal challenge over air traffic strikes, FT reports »

IAG and Ryanair are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNED

Barnes & Noble Education

$6.78

0.3 (4.63%)

, MU

Micron

$58.97

-0.26 (-0.44%)

19:00
06/20/18
06/20
19:00
06/20/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Barnes…

BNED

Barnes & Noble Education

$6.78

0.3 (4.63%)

MU

Micron

$58.97

-0.26 (-0.44%)

SCS

Steelcase

$15.55

0.2 (1.30%)

LITE

Lumentum

$56.45

0.8 (1.44%)

HPQ

HP Inc.

$23.31

-0.215 (-0.91%)

THO

Thor Industries

$104.81

6.5 (6.61%)

GLW

Corning

$28.40

0.015 (0.05%)

AOBC

American Outdoor Brands

$13.22

0.13 (0.99%)

LMNR

Limoneira

$26.65

0.63 (2.42%)

VERI

Veritone

$21.52

-0.64 (-2.89%)

TRUP

Trupanion

$41.07

0.8 (1.99%)

ARRS

Arris

$25.51

0.015 (0.06%)

WIX

Wix.com

$107.70

1.15 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 21

    Jun

  • 22

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

  • 12

    Jul

  • 21

    Jun

  • 21

    Jun

  • 21

    Jun

DIS

Disney

$107.28

1.08 (1.02%)

18:55
06/20/18
06/20
18:55
06/20/18
18:55
Periodicals
Disney puts future 'Star Wars' spinoffs on hold, Collider reports »

Disney's Lucasfilm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

SPY

SPDR S&P 500 ETF Trust

$276.00

0.52 (0.19%)

, SPX

S&P 500

$0.00

(0.00%)

18:54
06/20/18
06/20
18:54
06/20/18
18:54
Periodicals
Trump sees U.S. quarterly GDP going much higher, Bloomberg reports »

Says the head of U.S.…

SPY

SPDR S&P 500 ETF Trust

$276.00

0.52 (0.19%)

SPX

S&P 500

$0.00

(0.00%)

X

U.S. Steel

$35.72

0.56 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.